Low-dose Gemcitabine Combined With Nivolumab for Second-line and Above Line Treatment of NSCLC

Name: Low-dose Gemcitabine Combined With Nivolumab for Second-line and Above Line Treatment of NSCLC
License: Public Domain

Henan Cancer Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

non-small cell lung cancer metastatic

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 140986
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.